Dr. Sanjai Addla

Qualifications

• Post CCT fellowship in Uro-oncology at Christie Hospital, Manchester, UK in June 2009
• CCT in Urology at Higher surgical training, UK in May 2009
• Fellowship in Laparoscopy at Erasme Hospital, Brussels, Belgium in June 2008
• MD at University of Manchester in Oct 2010
• FRCS (Urol) at Intercollegiate Exam in June 2007
• MRCS (General Surgery) at RCS England in June 2000
• MBBS at APUHS, India in June 1997

Previous Posts Held

• Consultant Uro-oncological surgeon  BTHFT, Bradford, UK Nov 2009-July 2016
• Lead Cancer clinician
• Head of West of West Yorkshire Urology cancer network
• Head of Robotic surgery
• Clinical Lead for Urology

Scholarship and Funding Applications

• The Urological foundation robotic preceptorship of £18000 for advanced Robotic training in Nashville, Tennessee, USA in November 2013 
• Successful in getting a grant of £200,000 for Robotic programme in Bradford teaching hospitals from Sovereign Health care in April 2012
• Successful in getting a grant of £600,000 for Robotic programme in Bradford teaching hospitals from BTHFT charity fund in March 2012
• EUSP Clinical fellowship, 2008  
• The IPSEN fund training award, 2008
• BUF Clinical visit award, 2008
• BUF Blackwell Publishing/ Sackler Foundation Scholarship for the year 2005-06 

Academic Prizes and Achievements

• Invited to the British Parliament discussion on access to Robotic surgery in 2015.  
• Runners up in the Team of the year award from Bradford teaching hospitals for the year 2015.
• Established North of England Robotic Urological Surgeons (NERUS) group for sharing good practice and for collaboration on data sharing between the centers in 2014.  
• Principle surgeon in the first team in the North of England to undertake Robotic radical cystectomy and intracorporeal neobladder in Dec 2012
• Clinical excellence award in 2012, 2013, 2014 from Bradford teaching hospitals NHS foundation trust. 
• Best poster presentation for the session during 26^th Annual EAU Congress, Vienna, 2011
• Best poster presentation for the session during 22^nd Annual EAU Congress, Berlin, 2007
• Best poster presentation for the session during 21^st Annual EAU Congress, Paris, 2006
• Best poster presentation for the session during 20^th Annual EAU Congress, Istanbul, 2005
• Best poster presentation for the session during 19th Annual EAU Congress, Vienna, 2004
• The Best Reviewer Award for the year 2017 from Indian Journal of Urology awarded at the Annual meeting of USI, Jan 2018.

Research Experience

I have been involved in clinical research projects during my specialist registrar rotation and also have undertaken basic science laboratory based research during the research fellow post. 

‍Publications

Chapters in Books

1. Title of the Chapter: Trends in Prostate Cancer Screening – Overview of Europe
   Authors: SK Addla, B Djavan
   Title: Prostate cancer screening 2^nd Edition
   Editors: I Thompson, D Ankerst, C Tangen
   Details: 2^nd Edition, 2009, 35-51, Humana Press Inc, Totowa, NJ, USA
   ‍
2. Title of the Chapter: Intestinal and Urological Stomas: Surgical aspects
   Authors: A Jadav, NW Clarke, SKAddla, G Carlson
   Title: Abdominal Stomas and Their Skin Disorders
   Editors: CC Lyon, AJ Smith
   Details: 2^nd Edition, 2009, Martin Dunitz Ltd, London, Uk
   ‍
3. Title of Chapter: Introduction to PLAB and General surgical topics
   Authors:  H Kaukuntla, SL Daayana, SK Addla
   Title:  Plab Hand Book Part 2
   Details: 3^rd Edition, 2006, 1, 1-30, Paras Medical Books, Hyderabad, India

4. Title: Resuscitation and Mannequin 
   Authors: H Kaukuntla, N Shah, SK Addla, SL Daayana, K Henshall
   Title: Birmingham PLAB course-Teaching DVD for PLAB-2 (OSCE)
   Details: Birmingham PLAB course in association with South Manchester University Hospital NHS trust, UK

Peer Reviewed Publications

1. Local Anaesthetic  for Transrectal Ultrasound-Guided Prostate Biopsy: a prospective, randomised, double blind, placebo-controlled study.
   SK Addla, AAB Adeyoju, GD Wemyss-Holden, D Neilson
   European Urology, 2003,43,5,441-443

2. Diclofenac for Treatment of Nocturia caused by Nocturnal Polyuria: A Prospective, Randomised, Double-Blind placebo controlled crossover study.
   SK Addla, AB Adeyoju, D Neilson, P O’Reilly
   European Urology, 2006,49,720-726

3. Histological outcome of delayed orchidectomy followingprimary chemotherapy for metastatic germ cell tumour of the testis
   Ramani V, Grey B, Addla SK, Dunham M, Sangar V, Clarke N
   Clin Oncol (R Coll Radiol). 2008 Apr;20(3):247-52.

4. A simple aid to improve patient positioning during Percutaneous Nephrolithotomy
   Addla SK, Rajpal S, Sutcliffe N,Adeyoju A
   Ann R Coll Surg Engl.2008 Jul;90(5):433-4.

5. Characterizationof the Hoechst 33342 side population from normal and malignant human renalepithelial cells.
   Addla SK, Hart C, Ramani V, Brown M, Clarke N
   Am J Physiol RenalPhysiol. 2008 Sep; 295(3):F680-7

6. Phytotherapy inChronic prostatitis
   MC. Goris, T Roumeguere,SK Addla, CC. Schulman and B Djavan
   CurrentProstate Reports. 2009 Feb; 7(1): 39-43.

7. Hoechst 33342 side population identificationis a conserved and unified mechanism in urological cancers
   Oates JE, Grey BR, Addla SK, Samuel JD, Hart CA, Ramani V, Brown MD, Clarke NW.
   StemCells Dev.2009 Dec;18(10):1515-22

8. Avoid cruising on theUroflowmeter - Evaluation of cruising artefact on spinning disc flowmeter in anexperimental setup
   Addla SK, Marri RR, Daayana SL, Irwin PP
   NeurourolUrodyn. 2010 Sep;29(7):1301-5

9. Localising ProstateCancer: Comparison of Endorectal Magnetic Resonance (MR) Imaging and 3D-MRSpectroscopic Imaging with Transrectal Ultrasound guided biopsy.
   Goris Gbenou MC,Peltier A, Addla SK, Lemort M, Bollens R, Larsimont D, Roumeguere T, SchulmanCC, van Velthoven R.
   Urol Int. 2012;88(1):12-7

10. Partial nephrectomy:Comparison of open and robotic techniques in a single centresy.
    Clare Jelley, R Singh, HBardgett, SK Addla
    Journal of Clinical Urology, vol. 10, 1: pp. 28-35

11. Early surgical outcomes and oncological results of robot assisted partial nephrectomy: a multicenter study
    Veeratterapillay R, Addla SK,Jelley C, Bailie J, Rix D, Bromage S, Oakley  N, Weston R, Soomro NA.
    BJU Int. 2017 Oct ;120(4):550-555

12. Nephron-sparing surgery across a nation-outcomes from the British Association of urological surgeons 2012 national partial nephrectomy audit.
    BJU Int. 2016Jun;117(6):874-82

13. Nephrectomy for benign disease in the UK: results from the British Association of Urological Surgeons nephrectomy database
    BJU Int. 2016 Jan;117(1):138-44

14. Perioperative outcomes of 6042 nephrectomies in 2012: surgeon-reported results in the UK from the British Association of Urological Surgeons (BAUS) nephrectomy database
    BJU Int. 2015Jan;115(1):121-6

15. Who is at risk of death from nephrectomy? An analysis of thirty-day mortality after21 380      nephrectomies in 3 years ofthe British Association of Urological Surgeons (BAUS) National NephrectomyAudit.
    Fernando A, Fowler S,Van Hemelrijck M, O'Brien T; British Association of Urological Surgeons
    (BAUS). BJU Int. 2017 Sep;120(3):358-364

16. Assessment of Age and Duration of Symptoms on Outcomes of Emergency Scrotal Exploration for Acute Scrotal Pain.
    GM Nandwani, AAnwar, R Singh, AB Stewart, JA Forster, SK Addla
    J Coll Physicians SurPak.2020 Feb;30(2):201-204

17. Management ofCastration resistant prostate cancer (CRPC): Beyond chemotherapy
    GK Bakshi, SK Raghunath, S Rawal, G Gopalakrishnan,SK Addla, R Mittal
    J Urol Neph St, 2020Mar;2(5):196-205

18. Prostatecancer in British Asian Population: A case-control study.
    LRForster, C Jelley, CE Breeze, R Singh, R Chahal, SK Addla
    Journalof Clinical Urology, Dec 2020, Vol 14,3:179-183 doi.org/10.1177/2051415820969574

19. Gonadotropin-releasinghormone agonists in prostate cancer: A comparative review of efficacy andsafety.
    RajaT, Sud R, Addla S, Sarkar KK, Sridhar PS, Talreja V, Jain M, Patil K. IndianJ Cancer.
    2022Mar;59(Supplement):S142-S159. doi: 10.4103/ijc.IJC_65_21. PMID: 35343198

20. Exper tsurvey on management of prostate cancer in India: Real-world insights intopractice patterns.
    BakshiG, Tongaonkar H, Addla S, Menon S, Pradhan A, Kumar A, Bapat A, Gore A,Joshi A, Raja A, Bradoo A, Ramesh A, Kumar A, Agrawal A, Ambekar A, Joshi A,Singh A, Singh BP, Dabkara D, Khadakban D, Gautam G, Prakash G, Pahwa HS, GoelHK, Kulkarni J, Mishra JJ, Patel K, Pal M, Chibber PJ, Tiwari P, Naik R,Raghunath SK, Krishnatry R, Shimpi R, Sharma R, Taran R, Trivedi S, Nabar S,Surekha S, Kumar S, Sawaimoon SK, Raina S, Narasimha S, Advani S, Ghouse SM,Muddu VK, Maniar V, Venkat V, Murthy V. Indian J Cancer.
    Mar;59(Supplement):S19-S45.doi: 10.4103/ijc.ijc_1145_21. PMID: 35343189.